Teladoc (NYSE:TDOC) and Livongo Health (NSDQ:LVGO) today filed a joint proxy statement in connection with a proposed merger. Last month, the companies entered into a definitive merger agreement worth approximately $18.5 million. At the time, each share of Livongo was set to be exchanged for 0.5920 shares of Teladoc, plus cash consideration of $11.33 per Livongo share, […]
MedTech 100 roundup: Up-and-down week for industry
Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]
Livongo slides despite Street-beating Q2
Livongo Health (NSDQ:LVGO) shares took a hit today on second-quarter results that came in ahead of the consensus forecast. The Mountain View, Calif.-based company posted losses of -$1.6 million, or -2¢ per share, on sales of $91.9 million for the three months ended June 30, 2020, for an 88% bottom-line gain while more than doubling its […]
MedTech 100 roundup: Another high as stocks tick up
For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]
Teladoc to acquire Livongo for $18.5B
Teladoc (NYSE:TDOC) announced today that it entered into a definitive merger agreement with Livongo Health (NSDQ:LVGO) worth $18.5 billion. Purchase, N.Y.-based Teladoc and Mountain View, Calif.-based Livongo are setting out to improve the delivery, access and experience of healthcare around the world by offering high-quality, technology-enabled longitudinal care, according to a news release. Under the agreement, […]
Livongo announces $400m offering
Livongo Health (NSDQ:LVGO) announced that it intends to offer $400 million in a private offering of convertible senior notes. Mountain View, Calif.-based Livongo also plans to grant the initial purchasers of the notes, due in 2025, a 13-day option to purchase up to an additional $60 million, according to a news release. The notes will be […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Livongo beats The Street in Q4 results
Livongo Health (NSDQ:LVGO) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Mountain View, Calif.-based company reported losses of -$6 million, or -6¢ per share, on sales of $50.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 137.5% compared with Q4 2018. Adjusted to […]
Livongo inks deal with BCBS Kansas City
Livongo Health (NSDQ:LVGO) said yesterday that it expanded its partnership with Blue Cross & Blue Shield of Kansas City to offer its diabetes program to all of Blue KC’s fully insured clients. The agreement intends to make Livongo available to eligible administrative services only clients with Blue KC as well, according to a news release. Blue […]
Livongo jumps on federal employee benefits deal
Livongo Health (NSDQ:LVGO) shares jumped yesterday after the company landed a two-year deal with the Federal Employees Health Benefits Program that could add as much as $30 million a year to its top line. Mountain View, Calif.-based Livongo developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. Yesterday the […]
Livongo shares gain as first earnings print tops expectations
Livongo (NSDQ:LVGO) shares gained in pre-market trading today after the digital health company posted second-quarter results that beat the consensus forecast on Wall Street, in its first earnings print since its public flotation in July. Mountain View, Calif.-based Livongo said losses widened 129.3% to -$14.3 million, or 76¢ per share, on sales growth of 155.8% […]
